Evaluation of Kinesophobia in Patients With Metabolic Syndrome

• Sponsor: Erol Olcok Corum Training and Research Hospital (Other)
• Overall Status: Unknown status
• CT.gov ID: NCT04123132
• Collaborator: (none)
• Enrollment: 96
• Location: 1
• Anticipated Duration (Months): 4.2
• Patients Per Site Per Month: 22.7

Study Details

Study Description

Brief Summary

Metabolic syndrome (MS) is a public health problem characterized by central obesity, increased blood pressure and triglyceride levels, decreased blood HDL levels and the presence of insulin resistance (1).Kinesiophobia is a fear of irrational movement that develops because of its belief in susceptibility to injury and is associated with low levels of physical activity. Considering that exercise improves metabolic processes in people with MS, we aimed to evaluate the presence of kinesophobia in patients with MS.

Patients aged 45-65 years diagnosed with metabolic syndrome and healthy controls will be included in the study. Patients with rheumatic and neurological diseases,history of trauma, gonarthrosis, lumbar disc hernia, previous fractures, fibromyalgia and those who have experienced pain for the last week will be excluded. The participants will be filled in the Short Form-36 (SF-36), the Hospital Anxiety and Depression Scale, and the Tampa Kinesiophobia Scale. 48 patients with MS and 48 healthy participants will be included in the study.

Condition or Disease	Intervention/Treatment	Phase
Kinesiophobia; Metabolic Syndrome	Other: Kinesiophobia

Study Design

• Study Type: Observational
• Anticipated Enrollment: 96 participants
• Observational Model: Case-Control
• Time Perspective: Cross-Sectional
• Official Title: Evaluation of Kinesophobia in Patients With Metabolic Syndrome
• Actual Study Start Date: Sep 25, 2019
• Anticipated Primary Completion Date: Feb 1, 2020
• Anticipated Study Completion Date: Feb 1, 2020

Arms and Interventions

Arm	Intervention/Treatment
Patients with metabolic syndrome	Other: Kinesiophobia; The presence of kinesiofobia in patients with metabolic syndrome
Healthy controls

Outcome Measures

Primary Outcome Measures

1. Tampa Kinesiophobia Scale [3 months]

   People takes between 17-68 total a score. The score of the person shows high kinesiophobia on the scale

Eligibility Criteria

Criteria

• Ages Eligible for Study: 45 Years to 65 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• Patients with metabolic syndrome

Exclusion Criteria:

• Patients with rheumatic disease

• Patients with neurologic disease

• Patients with history of trauma

• Patients with gonartrosis

• Pateints with fibromialgia

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Dilek Eker Büyükşireci	Çorum	Central Anatolia	Turkey

Sponsors and Collaborators

• Erol Olcok Corum Training and Research Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Dilek Eker Büyükşireci, Specialist doctor, Erol Olcok Corum Training and Research Hospital
• ClinicalTrials.gov Identifier: NCT04123132
• Other Study ID Numbers: 08090081DEB
• First Posted: Oct 10, 2019
• Last Update Posted: Jan 10, 2020
• Last Verified: Jan 1, 2020

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Dilek Eker Büyükşireci, Specialist doctor, Erol Olcok Corum Training and Research Hospital: kinesiophobia; metabolic syndrome; exercise
• Additional relevant MeSH terms: Metabolic Syndrome; Syndrome

Study Results

No Results Posted as of Jan 10, 2020